Dynamic Navigation vs. the Freehand Method

Sponsor
University of Barcelona (Other)
Overall Status
Recruiting
CT.gov ID
NCT06028750
Collaborator
(none)
50
1
2
9
5.5

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate in novice surgeons the accuracy of the X-Guide® navigation system (X-Guide®, X-Nav Technologies®, Pennsylvania, USA) in implant placement compared to freehand implant placement.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dynamic Computer Assisted Surgery
  • Procedure: Freehand
N/A

Detailed Description

Randomized clinical trial with 2 parallel treatment groups. Eligible patients will be randomized with a 1:1 ratio to one of 2 possible parallel treatment groups:

  • Group 1: Nobel Replace Conical Connection® placed freehand.

  • Group 2: Nobel Replace Conical Connection® placed using the X-Guide guided surgery system (X-Nav Technologies®, Pennsylvania, USA).

PRIMARY OBJECTIVE:
  • To evaluate in novice surgeons the accuracy of the X-Guide® Navigation System (X-Guide®, X-Nav Technologies®, Pennsylvania, USA) in implant placement compared to freehand implant placement.
SECONDARY OBJECTIVES:
  • To evaluate overall surgical time with the X-Guide® Navigation System (X-Guide®, X-Nav Technologies®, Pennsylvania, USA) compared to freehand implant placement in inexperienced surgeons.

  • To evaluate Patient Reported Outcomes Measures (PROMs) during implant treatment with navigation systems performed by novice surgeons.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Accuracy of Dental Implant Placement Using Dynamic Navigation or the Freehand Method: a Randomized Controlled Clinical Trial in Novice Operators
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Freehand

Nobel Replace Conical Connection® placed freehand

Procedure: Freehand
Freehand implant placement

Experimental: X-Guide guided surgery system (X-Nav Technologies®, Pennsylvania, USA)

Nobel Replace Conical Connection® placed using the X-Guide guided surgery system (X-Nav Technologies®, Pennsylvania, USA)

Procedure: Dynamic Computer Assisted Surgery
Surgical navigation system (X-Guide guided surgery system) Navigation system X-Guide
Other Names:
  • Dynamic Navigation
  • Navigated surgery
  • Outcome Measures

    Primary Outcome Measures

    1. To evaluate in novice surgeons the accuracy of the X-Guide® navigation system (X-Guide®, X-Nav Technologies®, Pennsylvania, USA) in implant placement compared to freehand implant placement. [Through study completion, an average of 1 year.]

      The accuracy of placement of Nobel Replace Conical Connection® implants (Nobel Biocare) will be evaluated by superimposing the two cone-beam computed tomography (CBCT) (pre- and post-surgical) and calculating the deviations from the pre-operative planning and the final implant position. The superimposition of both CBCTs will be performed using X-Guide Standalone Planning Software (Nobel Biocare). The following variables will be analyzed for each implant: Angular deviation, Lateral platform deviation (2D), Global platform deviation (3D), Lateral apex deviation (2D), Apex depth deviation and Global apex deviation (3D).

    Secondary Outcome Measures

    1. To evaluate overall surgical time with the X-Guide® Navigation System (X-Guide®, X-Nav Technologies®, Pennsylvania, USA) compared to freehand implant placement in inexperienced surgeons. [During the surgical procedure.]

      Duration of the operation from the moment of anesthesia to the last suture point. In seconds (s).

    2. Comparison of Patient Reported Outcomes Measures (PROMs) between navigated and freehand surgery, using the Oral Health Impact Profile questionnaire, in addition to a PROMs questionnaire designed. [The OHIP-14 will be performed just before starting the surgery and at the 7-day postoperative control. The PROMs questionnaire will be performed by the patient just after finishing the implant surgery and having explained the postoperative instructions.]

      A questionnaire has been designed to evaluate the PROMs of patients treated with dynamic guided surgery and compare it with the PROMs of patients treated freehand: Prior to surgery the patient will complete the oral health impact profile questionnaire (OHIP-14sp). Immediately after the surgery and after explaining the postoperative instructions, the patient will fill in the questionnaire designed to evaluate PROMs. At 7 postoperative days, the patient will again complete the OHIP-14sp.

    3. Comparison of postoperative pain between navigated and freehand surgery, using a questionnaire designed with a visual analog scale (VAS). [The postoperative pain will be evaluated immediately after the surgery with a VAS questionnaire and during the 7 days following surgery.]

      A questionnaire has been designed to evaluate the postoperative pain of patients treated with dynamic guided surgery and compare it with patients treated freehand: Immediately after the surgery the patient will complete the VAS questionnaire. Another VAS questionnaire will be given to assess postoperative pain during the 7 days following surgery. The VAS questionnaire consists of a 100 mm visual analog scale (VAS). In the VAS questionnaire given for the 7 postoperative days there will be a VAS for each day and the analgesics and anti-inflammatory drugs consumed by the patient will be recorded. The VAS is formed by the value "No pain" to the left of the 100 mm straight line and by the value "Worst pain imaginable" to the right of the 100 mm straight line.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Subjects who agree to voluntarily sign the informed consent before performing any action related to the study.

    • Men or women at least 18 years old.

    • Single edentulous spaces or edentulous sections located in maxilla or mandible with a healing period longer than 12 weeks to rehabilitate with implant-supported fixed crowns ≤3 units.

    • O'Leary plaque and/or bleeding on probing index ≤25%.

    Exclusion Criteria:
    • Systemic diseases that may interfere with dental implant placement.

    • Any contraindications for oral surgical procedures.

    • History of head and neck radiotherapy.

    • Patients smoking >20 cigarettes/day or tobacco equivalents.

    • History of substance abuse (drugs or alcohol) or any other factor (e.g., severe psychiatric illness) that, in the opinion of the investigator, could interfere with the patient's ability to cooperate and comply with the study.

    • Patients who have participated in a clinical trial within the last 30 days.

    • Pregnant or lactating women.

    • Patients with poor or unmotivated oral hygiene.

    • Probing depth with bleeding of ≥4 mm in one of the teeth adjacent to the edentulous space or tract.

    • Need to perform guided bone regeneration procedures simultaneous to implant placement.

    • Cases where the use of transepithelial abutments is not recommended (reduced prosthetic space, high esthetic demand associated with thin gingival biotypes, etc.).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Barcelona L´hospitalet de Llobregat Catalunya Spain 08903

    Sponsors and Collaborators

    • University of Barcelona

    Investigators

    • Study Chair: Eduard Valmaseda Castellón, PhD, University of Barcelona

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Octavi Camps-Font, Associate Professor of Oral Surgery, University of Barcelona
    ClinicalTrials.gov Identifier:
    NCT06028750
    Other Study ID Numbers:
    • RCT X-GUIDE (50/2022)
    First Posted:
    Sep 8, 2023
    Last Update Posted:
    Sep 8, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Octavi Camps-Font, Associate Professor of Oral Surgery, University of Barcelona

    Study Results

    No Results Posted as of Sep 8, 2023